MEDIA RELEASE PR38413
OrthoAccel Technologies, Inc. Showcases AcceleDent at the World Federation of Orthodontists 7th
International Orthodontic Congress in Sydney, Australia
HOUSTON, Feb. 20 /PRNewswire-AsiaNet/ --
OrthoAccel Technologies, Inc., developers of the AcceleDent System, which
is an acceleration device to enhance orthodontics, recently exhibited at the
7th International Orthodontic Congress (IOC) in Sydney, Australia, which is
held by the World Federation of Orthodontists (WFO) every five years. The 8th
IOC in 2015 will be hosted in London.
AcceleDent is a simple dental device that orthodontic patients wear in the
mouth for 20 minutes daily to accelerate tooth movement. Michael Kaufman, VP
Business Development & Marketing at OrthoAccel, commented, "The purpose of our
visit to Australia was two-fold. We were able to introduce AcceleDent to the
Australian market and visit with a number of local orthodontic specialists. At
the same time, because of the international attendance, it provided an
opportunity to learn more about other global markets that may be of interest in
the future as we grow."
A Phase I clinical trial in 2008 in Houston, TX demonstrated device
safety. Dr. Chung H. Kau, DDS, MScD, MBA, PhD, M Orth, FDS, FFD (Ortho), FAMS
(Ortho), the principle investigator, was invited to Sydney as a speaker by the
WFO. In discussing AcceleDent with his colleagues, he observed, "I was
encouraged by how well tolerated the device was by patients - teenagers and
adults alike."
Kaufman continued, "The conference exceeded our expectations; we presented
and discussed AcceleDent with over 250 orthodontists from all over the world
who visited our exhibit. Additionally, we validated a high level of interest
in the Australian market and hope to begin shipping product to customers in the
second quarter, with partnership with an experienced and well respected local
distributor being the most likely channel." OrthoAccel was granted clearance
by the Australian Therapeutic Goods Administration in late 2009. Plans are to
make AcceleDent available on a limited basis to select Australian orthodontic
specialists.
The first case in private practice was initiated in October 2009 in the UK,
following EU approval. Dr. Gerry Bellman, who is currently treating that
particular patient, was in Sydney for the IOC. "I continue to be impressed by
the ease in which patients accept the appliance and the positive feedback from
them when they use it. We are anticipating faster case finishing. Safely
getting braces off sooner is important to both doctor and patient," remarked
Dr. Bellman.
OrthoAccel is anticipating the conclusion of another US clinical trial at
the UT Health Science Center in San Antonio with a target completion date later
in 2010.
About OrthoAccel Technologies, Inc.
Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned
medical device company currently engaged in the development, manufacturing, and
marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent System
AcceleDent represents the first clinical approach to safely accelerate
orthodontic tooth movement via modulating biology. The device has been studied
clinically and applies gentle pulsing forces in combination with standard
orthodontics to move teeth faster through accelerated bone remodeling.
Importantly, the device works complementary with all existing orthodontic
technologies. AcceleDent is neither FDA cleared nor FDA approved; it is
currently investigational only in the United States. More information can be
SOURCE: OrthoAccel Technologies, Inc.
CONTACT: Michael K. Lowe,
CEO of OrthoAccel Technologies, Inc.,
+1-832-631-1659
NEWS 
